Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice

Archives of Virology
Hai LiWenbo Xu

Abstract

Human respiratory syncytial virus (hRSV) is the primary cause of severe respiratory tract disease in children and infants as well as in elderly and immunocompromised adults. The fusion protein (F) of hRSV is the major antigen eliciting a neutralizing antibody response and protective immunity in the host, especially those recognizing the prefusion F protein (pre-F). In this study, we made genetic constructs for expression of a recombinant prefusion F protein in Pichia pastoris GS115, called RGF. Using Escherichia coli BL21, we expressed the pre-F and postfusion F protein (Post-F), called RBF and Post-RBF, respectively. RGF and RBF showed high affinity for 5C4, a highly potent monoclonal antibody specific for pre-F. We studied the immunogenicity of RGF and RBF in mice. Compared to mice immunized with formalin-inactivated RSV (FI-RSV), mice immunized with RGF or RBF exhibited superior protective immunity, which was confirmed by serum neutralizing activity and viral clearance after challenge. As judged from the IgG1/IgG2a ratios and numbers of IFN-γ- and IL-4-secreting cells, RGF or RBF with alum adjuvant induced a balanced Th1-biased immune response and produced no signs of enhanced respiratory disease (ERD) upon hRSV challenge. I...Continue Reading

References

Jun 16, 2004·Journal of Biotechnology·Laetitia BrunelEric Dubreucq
Jul 17, 2007·Vaccine·Shree R SinghEddie G Moore
Sep 13, 2008·Protein Expression and Purification·Helen A ArcuriFatima P de Souza
Feb 19, 2010·Current Microbiology·Xiao-Lan JingTong-Cun Zhang
Jun 19, 2013·Proceedings of the National Academy of Sciences of the United States of America·Lassi LiljeroosSarah Jane Butcher
Dec 18, 2013·Nature Reviews. Drug Discovery·Sarah Crunkhorn
Dec 24, 2013·Current Topics in Microbiology and Immunology·Jason S McLellanMark E Peeples
Mar 10, 2015·The Journal of Clinical Investigation·Jeanne H SchickliDavid R Milich
Mar 31, 2015·Current Opinion in Virology·Jason S McLellan
Sep 4, 2015·Nature Communications·Anders KrarupJohannes P M Langedijk
Aug 2, 2016·Nature Structural & Molecular Biology·M Gordon JoycePeter D Kwong
May 14, 2017·Current Opinion in Virology·Fariba RezaeeGiovanni Piedimonte
Apr 11, 2018·Archives of Virology·Gaya K AmarasingheJens H Kuhn
Feb 16, 2019·Drug Development and Industrial Pharmacy·Nirmal Marasini, Lisa M Kaminskas
Aug 3, 2019·Science·Michelle C CrankUNKNOWN VRC 317 Study Team

❮ Previous
Next ❯

Methods Mentioned

BETA
blood draws
bio-layer interferometry
size-exclusion chromatography
electron microscopy

Software Mentioned

Pro Plus
Image
GraphPad Prism

Related Concepts